title: Biobanking for health research in Brazil: present challenges and future directions.
abstract: This article outlines and discusses Brazil's new regulations on the use of human biological materials for research, specifically, Resolution CNS 441/11, enacted by the National Health Council of Brazil in May 2011, and the National Guidelines for Biorepositories and Biobanks (Ordinance No. 2201) published by the Ministry of Health in September 2011. The authors examine the differences between sample collections for single studies and large-scale collections for multiple studies (e.g., the National Tumor Bank at the Brazilian National Cancer Institute and the A. C. Camargo Hospital Biobank). Also discussed are the ethical and operational implications, i.e.,informed consent process, strategies for sample collection, custodianship, access to samples, and rules for disposal. Insights gained may be useful for developing national biobanking regulations in other countries in Latin America.
authors.affiliation: Brazilian Research Ethics Commission, Ministry of Health, Brasilia, Brazil.
authors.forename: Gabriela
authors.initials: G
authors.lastname: Marodin
authors.forename: Paulo
authors.initials: P
authors.lastname: França
authors.forename: Jose Claudio Casali da
authors.initials: JC
authors.lastname: Rocha
authors.forename: Antonio Hugo
authors.initials: AH
authors.lastname: Campos
mesh_terms: D018070:Biological Specimen Banks / Q000941:ethics / Q000331:legislation & jurisprudence* / Q000639:trends*; D035843:Biomedical Research / Q000331:legislation & jurisprudence* / Q000639:trends*; D001938:Brazil; D005544:Forecasting; D006801:Humans